Treatment of neovascular age-related macular degeneration: Current therapies.
about
Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayersCurrent treatments for radiation retinopathy.Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.Laser-targeted photosensitizer-induced lung injury: noninvasive rat model of pulmonary infarction.Effect of naringenin on NaIO(3)-induced retinal pigment epithelium degeneration and laser-induced choroidal neovascularization in rats.Laser treatment in 341 patients with exudative age-related macular degeneration.Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction.TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration.Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.PDGFR Inhibition Results in Pericyte Depletion and Hemorrhage into the Corpus Luteum of the Rat Ovary.Biodistribution and Pharmacokinetic Studies of a Porphyrin Dimer Photosensitizer (Oxdime) by Fluorescence Imaging and Spectroscopy in Mice Bearing Xenograft Tumors
P2860
Q24598616-13EB2ECB-CCF4-4F7F-A652-80C46836BAFBQ33665180-4321BE9C-C441-47B1-9CB8-A32CA73392A8Q33880596-EF97F967-D499-45FA-AEE1-EEA248D6422FQ34084807-00EEF287-1183-46C5-BABF-342D9D3EF5A2Q34254437-9E20BAEF-07BD-4EAF-984D-76B318C6BFCFQ34254566-36126241-D749-453F-A49C-1F30677C5F7BQ34433623-31B6E691-757E-48DA-A9C2-C95C7C8C8024Q34530196-8B03EEBA-6AE2-4DBA-A044-F1F260DC241BQ35038117-64FF633C-770B-4793-8538-C155126A11C0Q35736348-F49DE2BC-BCE7-4543-A7F2-6ADA203E4EB6Q39541853-F8452CFD-8847-42BE-A460-5392EAC04124Q53187474-F32F80B5-8459-4DD4-BFEF-BEC19FFD4FEDQ57699627-95B9D9CB-43BF-49AA-8F79-C277A7101395
P2860
Treatment of neovascular age-related macular degeneration: Current therapies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment of neovascular age-related macular degeneration: Current therapies.
@ast
Treatment of neovascular age-related macular degeneration: Current therapies.
@en
type
label
Treatment of neovascular age-related macular degeneration: Current therapies.
@ast
Treatment of neovascular age-related macular degeneration: Current therapies.
@en
prefLabel
Treatment of neovascular age-related macular degeneration: Current therapies.
@ast
Treatment of neovascular age-related macular degeneration: Current therapies.
@en
P2093
P2860
P356
P1476
Treatment of neovascular age-related macular degeneration: Current therapies.
@en
P2093
Albert J Augustin
Janna Kirchhof
Stefan Scholl
P2860
P304
P356
10.2147/OPTH.S3926
P407
P577
2009-06-02T00:00:00Z